EyeContact Dx

About

Q&A

What is EyeContact Dx's primary focus?

EyeContact Dx is developing software designed to detect autism spectrum disorders (ASD) in toddlers, aiming to provide advanced and accessible solutions for early ASD care.

What is EyeContact Dx's first product?

EyeContact Dx's first product is an eye-tracking-based screener, which is designed for seamless integration and to provide fast, reliable results for ASD detection.

When was EyeContact Dx founded?

EyeContact Dx was founded in April 2022.

Where is EyeContact Dx headquartered?

EyeContact Dx is headquartered in Rehovot, Center District, Israel.

What is the current employee count for EyeContact Dx?

EyeContact Dx has 11-50 employees.

What is EyeContact Dx's current funding stage?

EyeContact Dx is currently in the Pre-Funding stage.

Which sectors does EyeContact Dx operate in?

EyeContact Dx operates in Health Tech & Life Sciences, Digital Healthcare, and Digital Medical Diagnostics sectors.

What technologies does EyeContact Dx utilize?

EyeContact Dx utilizes Platforms & Interfaces, Software, and Artificial Intelligence technologies.

Who are the target customers for EyeContact Dx?

EyeContact Dx targets customers in Healthcare & Life Sciences, specifically Healthcare Providers.

What is the business model of EyeContact Dx?

EyeContact Dx operates on a B2B business model.

Team · 2

Aryeh Taub

Founder · Co-Founder (No longer with the company)

LinkedIn ↗

Hovav Dror

Founder · Co-Founder (No longer with the company)

LinkedIn ↗

Sectors & technology

Tags